Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Oral Triclofos Sodium: Dose - 100 mg/kg
Route of administration - orally in syrup form
Control Intervention1: Inj Dexmedetomidine-Ketamine: Dose - Inj. Dexmedetomidine 1 microgram/kg an
Sponsors
Khyati C Jethva
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and 2, Pediatric Patients age 6 months to 5 years, weight 5to18kg, Elective MRI
Exclusion criteria
Exclusion criteria: Congenital Heart Disease Liver/Kidney/Systemic/Metabolic Disease Anticipated Difficult Airway and Allergy to Study Drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ramsay Sedation score in Children undergoing MRITimepoint: Upto 6 hour from giving study drug | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Hemodynamics parameters (HR,RR,Spo2) 2. Onset of sedation, duration of sedation & total recovery time from sedation 3. the need for supplementation of rescue dose 4. Quality of MRI 5. Adverse effect of study drugTimepoint: 1.Hemodynamics parameters(HR,RR,Spo2)-120 mins 2.Onset of sedation, Duration of sedation & total recovery time from sedation- 6 hours 3. Need for supplementation of rescue dose- 1st,2nd,3rd dose, total dose. 4.Quality of MRI- Grade 1,2,3 5.Adverse effects of drugs- 6 hours | — |
Countries
India
Contacts
Public ContactMayurika J Patel
PDU Medical College, Rajkot
Outcome results
None listed